No Data
Yidu Tech's Loss Narrows in Fiscal H1 Despite Lower Revenue
One image to understand | Yidu Technology (02158) FY25 mid-term performance: Adjusted EBITDA continues to turn positive, with profit levels approaching last year's total.
Yidu Technology (02158) released the financial report for the six months ending September 30, 2024.
Medlinker Technology (2158.HK) announced its mid-year financial performance for the 2025 fiscal year, with a 29.2% decrease in year-on-year losses.
On November 21, AI medical industry leader iFlytek Technology (2158.HK) announced its mid-term performance for the 2025 fiscal year. During the reporting period, iFlytek Technology achieved an income of 0.329 billion yuan. Thanks to the improvement in internal operational efficiency and the enhanced synergies among various business sectors, the company's losses during the period were reduced to RMB 56.36 million, a year-on-year decrease of 29.2%. In addition, by continuously strengthening cash management and optimizing the efficiency of fund utilization, the net cash outflow from operating activities, excluding the impact of premiums and insurance claims collected and paid to third parties, narrowed by 10.8% year-on-year, with continuous optimization and improvement in cash flow. According to official sources...
YIDU TECH: INTERIM RESULTS ANNOUNCEMENTFOR THE SIX MONTHS ENDED 30 SEPTEMBER 2024
Hang Seng Index fell 0.12% in morning trading, AI applications are fully erupting.
U.S. stocks of Applovin continue to rise, driving a surge in AI applications across the board.
HK stocks change | iFlytek Technology (02158) soared nearly 9% to attract large single recently, will release interim results next Thursday.
Yidu Technology (02158) rose nearly 9% at its peak, and as of the time of writing, it is up 3.5%, priced at 5.92 Hong Kong dollars, with a transaction amount of 0.141 billion Hong Kong dollars.
Here's Why We're Not At All Concerned With Yidu Tech's (HKG:2158) Cash Burn SituationNo Data
No Data
